Tevogen Bio Holdings Inc. (TVGNW) — 10-Q Filings

10-Q Filings (6)

• Tevogen Bio's Net Loss Widens to $21.6M Amid Funding Dependence — Nov 14, 2025 Risk: high
  Tevogen Bio Holdings Inc. (TVGNW) reported a net loss of $21,597,852 for the nine months ended September 30, 2025, a significant increase from the $4,282,828 ne
• Tevogen Bio Holdings Files 10-Q for Q2 2025 — Aug 14, 2025 Risk: medium
  Tevogen Bio Holdings Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly Semper Paratus Acquisition Corp, is focused on biological pr
• Tevogen Bio Holdings Inc. Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  Tevogen Bio Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Semper Paratus Acquisition Corp., is in the biological prod
• Tevogen Bio Holdings Files Q3 2024 10-Q — Nov 19, 2024 Risk: medium
  Tevogen Bio Holdings Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Semper Paratus Acquisition Corp., is involved in biolog
• Tevogen Bio Holdings: Reduced Net Loss in H1 2024 — Aug 14, 2024 Risk: high
  Tevogen Bio Holdings Inc. filed its 10-Q for the period ending June 30, 2024. The company reported no revenue for the three and six months ended June 30, 2024,
• Tevogen Bio Holdings Files Q1 2024 10-Q — May 28, 2024 Risk: medium
  Tevogen Bio Holdings Inc. filed its Q1 2024 10-Q report on May 28, 2024, covering the period ending March 31, 2024. The company, formerly Semper Paratus Acquisi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX